PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,533,000 | +3.6% | 486,929 | -4.2% | 0.00% | – |
Q2 2020 | $1,480,000 | +3.0% | 508,504 | -0.2% | 0.00% | – |
Q1 2020 | $1,437,000 | -20.6% | 509,563 | -8.6% | 0.00% | – |
Q4 2019 | $1,809,000 | +41.5% | 557,360 | -5.8% | 0.00% | – |
Q3 2019 | $1,278,000 | -38.1% | 591,741 | -10.0% | 0.00% | -100.0% |
Q2 2019 | $2,066,000 | -23.1% | 657,796 | -8.9% | 0.00% | 0.0% |
Q1 2019 | $2,686,000 | +28.1% | 721,994 | -0.2% | 0.00% | 0.0% |
Q4 2018 | $2,097,000 | -39.5% | 723,114 | -45.2% | 0.00% | 0.0% |
Q3 2018 | $3,468,000 | +15.5% | 1,318,645 | +2.8% | 0.00% | 0.0% |
Q2 2018 | $3,002,000 | -19.9% | 1,283,028 | +0.6% | 0.00% | 0.0% |
Q1 2018 | $3,748,000 | +6.4% | 1,274,992 | -0.8% | 0.00% | 0.0% |
Q4 2017 | $3,522,000 | -50.4% | 1,285,346 | -38.6% | 0.00% | -50.0% |
Q3 2017 | $7,097,000 | +35.4% | 2,093,321 | -1.3% | 0.00% | +100.0% |
Q2 2017 | $5,241,000 | +8.5% | 2,121,872 | -0.3% | 0.00% | 0.0% |
Q1 2017 | $4,830,000 | +14.3% | 2,127,651 | +6.8% | 0.00% | 0.0% |
Q4 2016 | $4,224,000 | -19.1% | 1,992,265 | +27.9% | 0.00% | -50.0% |
Q3 2016 | $5,219,000 | -54.0% | 1,557,964 | -56.9% | 0.00% | -33.3% |
Q2 2016 | $11,357,000 | +0.1% | 3,616,878 | +6.2% | 0.00% | 0.0% |
Q1 2016 | $11,346,000 | -4.4% | 3,407,024 | +1.6% | 0.00% | -25.0% |
Q4 2015 | $11,873,000 | -14.0% | 3,353,903 | +22.2% | 0.00% | 0.0% |
Q3 2015 | $13,810,000 | -26.7% | 2,745,427 | -6.3% | 0.00% | -20.0% |
Q2 2015 | $18,836,000 | -4.4% | 2,929,430 | +4.6% | 0.01% | 0.0% |
Q1 2015 | $19,709,000 | -83.4% | 2,801,453 | -81.8% | 0.01% | -83.9% |
Q4 2014 | $118,585,000 | +4.2% | 15,380,682 | +1.0% | 0.03% | 0.0% |
Q3 2014 | $113,797,000 | -61.3% | 15,233,836 | -49.9% | 0.03% | -22.5% |
Q2 2014 | $294,310,000 | +124.6% | 30,403,742 | +92.8% | 0.04% | +11.1% |
Q1 2014 | $131,021,000 | -0.2% | 15,766,856 | +1.3% | 0.04% | -2.7% |
Q4 2013 | $131,341,000 | -46.3% | 15,561,779 | -49.3% | 0.04% | 0.0% |
Q3 2013 | $244,598,000 | +114.7% | 30,689,734 | +108.0% | 0.04% | +2.8% |
Q2 2013 | $113,917,000 | – | 14,756,212 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |